Clearance Summary
Minder System received FDA 510(k) clearance under submission number DEN240062, sponsored by Epi-Minder Pty, Ltd.. The device was reviewed via the Direct premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2025-04-17.
- Submission: DEN240062
- Applicant / Sponsor: Epi-Minder Pty, Ltd.
- Clearance pathway: Direct
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.1360
- Decision date: 2025-04-17
Classification & Regulation
This clearance is catalogued under FDA product code SEM and 21 CFR 882.1360, within the Neurology review panel as a Class II device.